DNA synthesis in leukemic cells under the action of cytotoxic agents in vitro and in vivo.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002478:Cells, Cultured; D003561:Cytarabine / Q000494:pharmacology / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D003630:Daunorubicin / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D007938:Leukemia / Q000188:drug therapy* / Q000378:metabolism*; D007945:Leukemia, Lymphoid / Q000378:metabolism; D015470:Leukemia, Myeloid, Acute / Q000378:metabolism; D007962:Leukocytes / Q000378:metabolism; D008297:Male; D008727:Methotrexate / Q000494:pharmacology / Q000627:therapeutic use; D008875:Middle Aged; D011379:Prognosis; D013942:Thymine Nucleotides / Q000096:biosynthesis; D014316:Tritium
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D005938:Glucocorticoids; D013942:Thymine Nucleotides; D003561:Cytarabine; D014316:Tritium; D008727:Methotrexate; D003630:Daunorubicin